FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Methotrexate Tablets, USP
Status: Discontinuation
»Therapeutic Categories: Dermatology; Oncology; Rheumatology

Expand all

Endo Pharmaceuticals, Inc. (New 09/13/2019)

Company Contact Information:
800-462-3636

Presentation Posting Date Related Information
Methotrexate Sodium 2.5 mg Tablet, 36 count (NDC 67253-320-36) 09/13/2019 Endo has made a business decision to permanently discontinue the drug product.
Methotrexate Sodium 2.5 mg Tablet, 100 count (NDC 67253-320-10) 09/13/2019 Endo has made a business decision to permanently discontinue the drug product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English